A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

BACKGROUND: This multicentre randomised phase III trial was designed to determine whether adjuvant chemotherapy with gemcitabine improves the outcomes of patients with resected pancreatic cancer. METHODS: Eligibility criteria included macroscopically curative resection of invasive ductal carcinoma o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ueno, H, Kosuge, T, Matsuyama, Y, Yamamoto, J, Nakao, A, Egawa, S, Doi, R, Monden, M, Hatori, T, Tanaka, M, Shimada, M, Kanemitsu, K
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2009
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743365/
https://ncbi.nlm.nih.gov/pubmed/19690548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605256
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki